Advanced Rheumatology, PC

Advanced Rheumatology, PC was paid $693K by Medicaid between Jan 2018 and Dec 2024, across 19 billing codes. Its largest line is J1602, Injection, golimumab, 1 mg, for intravenous use — 34% of everything it billed.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	2,387	$168K
2019	1,875	$123K
2020	1,367	$110K
2021	1,105	$100K
2022	859	$90K
2023	798	$58K
2024incomplete	844	$44K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
J1602	Injection, golimumab, 1 mg, for intravenous use	34%	355	351	$234K
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	30%	3,848	3,720	$208K
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	13%	1,955	1,737	$92K
J0129	Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	11%	65	25	$79K
99204	Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity	5.2%	430	414	$36K
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	4.8%	900	857	$34K
96375	Therapeutic injection; each additional sequential IV push	<1%	420	348	$2K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	259	245	$2K
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	175	165	$1K
99442		<1%	38	38	$1K
96415		<1%	58	54	$806.92
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	122	112	$732.59

7 more codes

G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established)	<1%	158	$647.22
90674		<1%	28	$562.60
90756		<1%	22	$364.64
20610		<1%	18	$347.34
J1040	Injection, methylprednisolone acetate, 80 mg	<1%	32	$271.42
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	37	$252.00
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	315	$121.97

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialSALLIOTTE, JAMES (BUSINESS MANAGER)